RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/30354720http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30354720http://www.w3.org/2000/01/rdf-schema#comment"Primary aldosteronism affects ≈5% to 10% of hypertensive patients and has unilateral and bilateral forms. Most unilateral primary aldosteronism is caused by computed tomography-detectable aldosterone-producing adenomas, which express CYP11B2 (aldosterone synthase) and frequently harbor somatic mutations in aldosterone-regulating genes. The cause of the most common bilateral form of primary aldosteronism, idiopathic hyperaldosteronism (IHA), is believed to be diffuse hyperplasia of aldosterone-producing cells within the adrenal cortex. Herein, a multi-institution cohort of 15 IHA adrenals was examined with CYP11B2 immunohistochemistry and next-generation sequencing. CYP11B2 immunoreactivity in adrenal glomerulosa harboring non-nodular hyperplasia was only observed in 4/15 IHA adrenals suggesting that hyperplasia of CYP11B2-expressing cells may not be the major cause of IHA. However, the adrenal cortex of all IHA adrenals harbored at least 1 CYP11B2-positive aldosterone-producing cell cluster (APCC) or micro-aldosterone-producing adenomas. The number of APCCs per case (and individual APCC area) in IHA adrenals was significantly larger than in normotensive controls. Next-generation sequencing of DNA from 99 IHA APCCs demonstrated somatic mutations in genes encoding the L-type calcium voltage-gated channel subunit α 1-D ( CACNA1D, n=57; 58%) and potassium voltage-gated channel subfamily J-5 ( KCNJ5, n=1; 1%). These data suggest that IHA may result from not only hyperplasia but also the accumulation or enlargement of computed tomography-undetectable APCC harboring somatic aldosterone-driver gene mutations. The high prevalence of mutations in the CACNA1D L-type calcium channel provides a potential actionable therapeutic target that could complement mineralocorticoid blockade and inhibit aldosterone overproduction in some IHA patients."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.org/dc/terms/identifier"doi:10.1161/hypertensionaha.118.11086"xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Guo Z."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Ito S."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Nakamura Y."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Yamazaki Y."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Omata K."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Sasano H."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Rainey W.E."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Stowasser M."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Anand S.K."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Morimoto R."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Satoh F."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/author"Tomlins S.A."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/name"Hypertension"xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/pages"874-880"xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/title"Cellular and Genetic Causes of Idiopathic Hyperaldosteronism."xsd:string
http://purl.uniprot.org/citations/30354720http://purl.uniprot.org/core/volume"72"xsd:string
http://purl.uniprot.org/citations/30354720http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/30354720
http://purl.uniprot.org/citations/30354720http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/30354720
http://purl.uniprot.org/uniprot/#_A0A1B0GUN6-mappedCitation-30354720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30354720
http://purl.uniprot.org/uniprot/#_A0A7G9IPG1-mappedCitation-30354720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30354720
http://purl.uniprot.org/uniprot/#_B7Z269-mappedCitation-30354720http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30354720